{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:06:21Z","timestamp":1781129181343,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedic Science"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jos.2020.05.016","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T17:31:42Z","timestamp":1595525502000},"page":"684-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Modulation of spine fusion with BMP-2, MEK inhibitor (PD0325901), and zoledronic acid in a murine model of NF1 double inactivation"],"prefix":"10.1016","volume":"26","author":[{"given":"Justin D.","family":"Bobyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7757-6281","authenticated-orcid":false,"given":"Aaron","family":"Schindeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jos.2020.05.016_bib1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol"},{"issue":"8 Suppl","key":"10.1016\/j.jos.2020.05.016_bib2","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1097\/00007632-199208001-00005","article-title":"Prevalence of scoliosis in neurofibromatosis","volume":"17","author":"Akbarnia","year":"1992","journal-title":"Spine"},{"issue":"245","key":"10.1016\/j.jos.2020.05.016_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00003086-198908000-00007","article-title":"Pitfalls of spinal deformities associated with neurofibromatosis in children","author":"Crawford","year":"1989","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"10.1016\/j.jos.2020.05.016_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1148\/radiology.162.3.3101136","article-title":"Spinal and paraspinal neurofibromatosis: surface coil MR imaging at 1.5 T1","volume":"162","author":"Burk","year":"1987","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.jos.2020.05.016_bib5","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00586-010-1464-0","article-title":"Surgical correction of severe dystrophic neurofibromatosis scoliosis: an experience of 32 cases","volume":"19","author":"Koptan","year":"2010","journal-title":"Eur Spine J"},{"issue":"7","key":"10.1016\/j.jos.2020.05.016_bib6","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/BRS.0000000000001455","article-title":"Morphological differences in the vertebrae of scoliosis secondary to neurofibromatosis type 1 with and without paraspinal neurofibromas","volume":"41","author":"Hu","year":"2016","journal-title":"Spine"},{"issue":"5","key":"10.1016\/j.jos.2020.05.016_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00586-004-0829-7","article-title":"Spinal deformity in neurofibromatosis type-1: diagnosis and treatment","volume":"14","author":"Tsirikos","year":"2005","journal-title":"Eur Spine J"},{"issue":"2","key":"10.1016\/j.jos.2020.05.016_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2214\/ajr.180.2.1800413","article-title":"MR imaging of spinal tumors in children with neurofibromatosis 1","volume":"180","author":"Khong","year":"2003","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.jos.2020.05.016_bib9","first-page":"1071","article-title":"Spinal MR findings in neurofibromatosis types 1 and 2","volume":"13","author":"Egelhoff","year":"1992","journal-title":"Am J Neuroradiol"},{"issue":"9","key":"10.1016\/j.jos.2020.05.016_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s002340050814","article-title":"Spinal tumours in neurofibromatosis type 1: an MRI study of frequency, multiplicity and variety","volume":"41","author":"Thakkar","year":"1999","journal-title":"Neuroradiology"},{"issue":"2","key":"10.1016\/j.jos.2020.05.016_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1302\/0301-620X.71B2.2494186","article-title":"Scoliosis in neurofibromatosis. The natural history with and without operation","volume":"71-B","author":"Calvert","year":"1989","journal-title":"J\u00a0Bone Joint Surg Br"},{"issue":"Suppl 1","key":"10.1016\/j.jos.2020.05.016_bib12","first-page":"123","article-title":"The immature spine in type-1 neurofibromatosis","volume":"89","author":"Crawford","year":"2007","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"3","key":"10.1016\/j.jos.2020.05.016_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1302\/0301-620X.58B3.956246","article-title":"Pseudoarthrosis after spinal fusion for scoliosis","volume":"58","author":"McMaster","year":"1976","journal-title":"J\u00a0Bone Joint Surg Br"},{"issue":"6","key":"10.1016\/j.jos.2020.05.016_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11832-010-0293-3","article-title":"Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia","volume":"4","author":"Birke","year":"2010","journal-title":"J\u00a0Child Orthop"},{"issue":"8","key":"10.1016\/j.jos.2020.05.016_bib15","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/jor.22628","article-title":"Maximizing bone formation in posterior spine fusion using rhBMP-2 and zoledronic acid in wild type and NF1 deficient mice","volume":"32","author":"Bobyn","year":"2014","journal-title":"J\u00a0Orthop Res"},{"issue":"1","key":"10.1016\/j.jos.2020.05.016_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jbmr.528","article-title":"A\u00a0murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells","volume":"27","author":"El-Hoss","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jos.2020.05.016_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jim.2007.11.013","article-title":"Use of Cre-adenovirus and CAR transgenic mice for efficient deletion of genes in post-thymic T cells","volume":"331","author":"Zha","year":"2008","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jos.2020.05.016_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1749-799X-8-2","article-title":"Posterolateral inter-transverse lumbar fusion in a mouse model","volume":"8","author":"Bobyn","year":"2013","journal-title":"J\u00a0Orthop Surg Res"},{"issue":"6","key":"10.1016\/j.jos.2020.05.016_bib19","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bone.2011.09.043","article-title":"JNK inhibitors increase osteogenesis in Nf1-deficient cells","volume":"49","author":"Sullivan","year":"2011","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.jos.2020.05.016_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jor.20481","article-title":"Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice","volume":"26","author":"Schindeler","year":"2008","journal-title":"J\u00a0Orthop Res"},{"issue":"3","key":"10.1016\/j.jos.2020.05.016_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bone.2010.06.001","article-title":"Osteoclasts in neurofibromatosis type 1 display enhanced resorption capacity, aberrant morphology, and resistance to serum deprivation","volume":"47","author":"Heerv\u00e4","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.jos.2020.05.016_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bone.2013.11.013","article-title":"Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib)","volume":"59","author":"El-Hoss","year":"2014","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.jos.2020.05.016_bib23","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-005-1940-2","article-title":"Decreased bone mineral density in patients with neurofibromatosis 1","volume":"16","author":"Lammert","year":"2005","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.jos.2020.05.016_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpeds.2006.10.048","article-title":"Bone mineral density in children and adolescents with neurofibromatosis type 1","volume":"150","author":"Stevenson","year":"2007","journal-title":"J\u00a0Paediatrics"},{"issue":"1","key":"10.1016\/j.jos.2020.05.016_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12031-019-01277-0","article-title":"NF1 somatic mutation in dystrophic scoliosis","volume":"68","author":"Margraf","year":"2019","journal-title":"J\u00a0Mol Neurosci"},{"issue":"5","key":"10.1016\/j.jos.2020.05.016_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.semcdb.2008.07.004","article-title":"Bone remodeling during fracture repair: the cellular picture","volume":"19","author":"Schindeler","year":"2008","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.jos.2020.05.016_bib27","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/jor.23672","article-title":"Improved union and bone strength in a mouse model of NF1 pseudarthrosis treated with recombinant human bone morphogenetic protein-2 and zoledronic acid","volume":"36","author":"Deo","year":"2018","journal-title":"J\u00a0Orthop Res"},{"issue":"Supp 13","key":"10.1016\/j.jos.2020.05.016_bib28","doi-asserted-by":"crossref","first-page":"CT046","DOI":"10.1158\/1538-7445.AM2017-CT046","article-title":"Abstract CT046: phase I dose escalation study of the CDK4\/6 inhibitor palbociclib in combination with the MEK inhibitor PD-0325901 in patients with RAS mutant solid tumors","volume":"77","author":"Shapiro","year":"2017","journal-title":"Can Res"},{"issue":"Suppl 2","key":"10.1016\/j.jos.2020.05.016_bib29","first-page":"S220","article-title":"Could an osteoinductor result in degeneration of a neurofibroma in NF1?","volume":"19","author":"Steib","year":"2010","journal-title":"Eur Spine J"}],"container-title":["Journal of Orthopaedic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265820301810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265820301810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:33:18Z","timestamp":1760556798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0949265820301810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0949265820301810"],"URL":"https:\/\/doi.org\/10.1016\/j.jos.2020.05.016","relation":{},"ISSN":["0949-2658"],"issn-type":[{"value":"0949-2658","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of spine fusion with BMP-2, MEK inhibitor (PD0325901), and zoledronic acid in a murine model of NF1 double inactivation","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedic Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jos.2020.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier B.V. on behalf of The Japanese Orthopaedic Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}